Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Profound Medical Corp PROF


Primary Symbol: T.PRN

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure... see more

TSX:PRN - Post Discussion

Profound Medical Corp > More Share Bought by Profound Medical's management
View:
Post by Charlie263 on May 18, 2022 12:04am

More Share Bought by Profound Medical's management

It's important to note that following purchases has been made in the month of May 2022:
Arun Menawat puchased 60516 shares, in addition to his previous puchases in Mar 2022
Brian Ellacott purchased 50000 shares
Ken Knudson Purchased 8000 shares.

It seems Profound medical's team did spectecular presentations of TULSA PRO at AUA. To me it seems, the rise of Profound Medical is imminent.
Comment by MrMugsy on May 23, 2022 3:42pm
Should be imminent - very much tied to hospitals, reimbursement and a permanent reimbursement code.
Comment by BuenaSuertaAtod on May 26, 2022 9:54am
In the Q2 conf call they indicated that the lack of a permanent reimbursement code was not holding them back in any significant way. That's a good thing considering that they said then they were targeting Q4 2022 to apply for a permanent code, with Jan 2024 being the target date for actually having a permanent code. How much difference does a permanent reimbursement code make? I can't ...more  
Comment by MrMugsy on Jun 07, 2022 10:06pm
Covid was holding them back via implementing the hospitals - not the reimbursement code. But what I'm talking about is their growth rate.  The permanent code is key to the growth rate in the future.  When Profound started in the USA, they didn't have a code (or even the use of a temporary) so the initial patients were all out of pocket. Then hospitals started using an existing ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities